Helping manufacturers define the characteristics of their devices and determine the appropriate regulatory qualification and classification.
Similar Posts
Guidance: The Innovative Devices Access Pathway (IDAP)
The Innovative Devices Access Pathway (IDAP) pilot is designed to accelerate the development of innovative medical devices that meet an unmet clinical need in the NHS and support their integration into the UK market.
Strengthening collaboration between the MHRA and the Department of Health Northern Ireland
The MHRA and Northern Ireland partners are working together to support innovation, enhance patient safety and ensure people in Northern Ireland benefit from world-class regulation.
Brensocatib licensed as the first medicine specifically designed to treat non-cystic fibrosis bronchiectasis in patients 12 years and older
As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review.
Good clinical practice for clinical trials
How to show the MHRA you’re meeting good clinical practice (GCP) standards and what to expect from an inspection.
Medical devices: conformity assessment and the UKCA mark
How to conform with the legal requirements for placing medical devices on the market.
Guidance: Medical devices: post-market surveillance requirements
How to interpret post-market surveillance (PMS) requirements for medical devices in Great Britain.